With shares of Procter & Gamble (NYSE:PG) trading at around $78.03, is PG an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
C = Catalyst for the Stock’s Movement
Procter & Gamble has made many changes recently, but all the fear surrounding the company seems to have been overplayed. This even includes insiders. Sometimes an outsider is more accurate simply because every little detail isn’t being overanalyzed. Procter & Gamble has many positives, including:
- Strong cost savings
- Consistent innovation (Tide Pods, Always Radiance, Bounty Trap & Lock, Bounty Unstoppables)
- Diversified product portfolio
- Excellent marketing
- Brand recognition
- Emerging market growth (40 percent of sales vs. 20 percent of sales in 2003)
Procter & Gamble’s restructuring means four sectors opposed to five beginning July 1, 2013. These sectors will include:
- Global Baby, Feminine and Family Care
- Global Beauty
- Global Health and Grooming
- Global Fabric and Home Care
As you can see, there is a big emphasis on global.
As far as revenue goes, it has increased on an annual basis. Earnings have been inconsistent, but profits are always healthy. On a year-over-year basis, revenue increased 2 percent last quarter, and earnings increased 6.40 percent. If you exclude Wall Street expectations, Procter & Gamble is doing just fine.
As far as valuation is concerned, Procter & Gamble is trading at 17 times earnings whereas Johnson & Johnson (NYSE:JNJ) is trading at 23 times earnings and Kimberly-Clark (NYSE:KMB) is trading at 21 times earnings. However, all three of these companies are long-term winners. And Procter & Gamble is trading at 18 times forward earnings whereas Johnson & Johnson is trading at 15 times forward earnings and Kimberly-Clark is trading at 16 times forward earnings. Procter & Gamble and Johnson & Johnson have the most impressive profit margins at 15.61 percent and 15.22 percent, respectively. Kimberly-Clark has a profit margin of 8.58 percent. In regards to yield, the numbers are once again similar. Procter & Gamble currently yields 3.10 percent, Johnson & Johnson yields 3.20 percent, and Kimberly-Clark yields 3.30 percent.
Procter & Gamble is cutting $10 billion in costs by 2016. Many of these cuts will come via the workforce. These cuts (not just in the workforce, but in an overall sense) should help improve margins and improve earnings. However, Procter & Gamble still has growth potential as well, especially in emerging markets.
All that said, there are negatives for Procter & Gamble as well, which include:
- A weak consumer
- High gas costs
- Rising interest rates
- Unemployment and underemployment
- Weakness in Europe
- Competitive pricing
- Soft beauty sales (Procter & Gamble is highly focused on improving in this area)
- Weak guidance
In regards to company culture, it’s strong at Procter & Gamble. This is a good sign because happy workers often mean increased productivity. Despite Procter & Gamble planning layoffs of 2 percent to 4 percent of the workforce every year through 2016, employees have still rated their employer a 3.9 of 5, and 88 percent of employees would recommend the company to a friend.
Let’s take a look at some more important numbers prior to forming an opinion on this stock.
T = Technicals Are Mixed
Procter & Gamble hasn’t performed well over the past months, but it has been steady over a three-year time frame.
|1 Month||Year-To-Date||1 Year||3 Year|
At $78.03, Procter & Gamble is trading below its 50-day SMA, but still above its 200-day SMA.
E = Equity to Debt Ratio Is Normal
The debt-to-equity ratio for Procter & Gamble is close to the industry average of 0.50.
E = Earnings Have Been Steady
Earnings haven’t consistently grown on an annual basis, but they have been steady within a range.
|Revenue ($) in millions||83,503||79,029||78,938||82,559||83,680|
|Diluted EPS ($)||3.64||4.26||4.11||3.93||3.66|
Looking at the last quarter on a year-over-year basis, revenue and earnings both improved.
|Quarter||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||20,194||20,212||20,739||22,175||20,598|
|Diluted EPS ($)||0.82||1.24||0.96||1.39||0.88|
Now let’s take a look at the next page for the Conclusion. Is this stock an OUTPERFORM, a WAIT AND SEE, or a STAY AWAY?
Procter & Gamble might be dealing with several headwinds at the moment, but this is a company that has survived many storms in the past. With a strong management in place and clear-cut goals that are likely to be effective, Procter & Gamble should remain a long-term winner.
Procter & Gamble is an OUTPERFORM.
Using a solid investing framework such as this can help improve your stock-picking skills. Don’t waste another minute — click here and get our CHEAT SHEET stock picks now.
All content posted should not be considered professional advice. Please do your own research and consult with a professional financial advisor before making any investment decisions. I don’t have any positions in this stock.